Which hedge funds own AXSM? AXSOME THERAPEUTICS INC., Q2 2026 13F holders
Healthcare · Open on the interactive board
12 of the hedge funds tracked by WhaleCreep disclosed a position in AXSM (AXSOME THERAPEUTICS INC.) in their Q2 2026 13F filings, worth $653.3m in total. The largest holder by portfolio weight is Point72 Asset Management LP at 0.2% of its book. 2 managers opened a new position this quarter: Brevan Howard Capital Management, Tudor Investment. 1 exited: Farallon Capital Management.
12tracked managers holding
2opened this quarter
1exited this quarter
Which hedge funds hold AXSM? Current holders by portfolio weight
| Manager | As of | Weight of book | Value | Shares | Δ shares | Action |
|---|---|---|---|---|---|---|
| Point72 Asset Management LP | Q2 2026 | 0.2% | $102.0m | 416,516 | -2% | reduced |
| Woodline Partners | Q2 2026 | 0.1% | $39.7m | 162,221 | 0% | held |
| Brevan Howard Capital Management | Q2 2026 | 0.1% | $7.8m | 31,928 | – | new |
| Millennium Management | Q2 2026 | 0.1% | $136.1m | 556,088 | 2579% | added |
| D. E. Shaw & Co | Q2 2026 | 0.1% | $148.0m | 604,753 | 0% | held |
| Renaissance Technologies LLC | Q2 2026 | 0.1% | $64.1m | 262,000 | 59% | added |
| Bridgewater Associates | Q2 2026 | 0.1% | $14.2m | 58,217 | 2% | added |
| Marshall Wace | Q2 2026 | 0.0% | $54.7m | 223,386 | 58% | added |
| Citadel Advisors | Q2 2026 | 0.0% | $62.6m | 255,878 | -9% | reduced |
| WCM Investment Management | Q2 2026 | 0.0% | $18.3m | 75,713 | -30% | reduced |
| Tudor Investment | Q2 2026 | 0.0% | $4.6m | 18,950 | – | new |
| Polen Capital Management | Q2 2026 | 0.0% | $1.1m | 4,468 | 111% | added |
Exited since the previous quarter
| Manager | Prior weight | Prior value |
|---|---|---|
| Farallon Capital Management | 0.0% | $676.1k |
How has hedge fund ownership of AXSM changed?
| Quarter | Managers holding | Combined value |
|---|---|---|
| Q2 2026 | 12 | $653.3m |
| Q1 2026 | 11 | $331.9m |
| Q4 2025 | 6 | $88.0m |
| Q3 2025 | 5 | $75.4m |
| Q2 2025 | 8 | $119.9m |
| Q1 2025 | 8 | $98.3m |
| Q4 2024 | 6 | $160.6m |
| Q3 2024 | 7 | $205.0m |
| Q2 2024 | 7 | $185.9m |
| Q1 2024 | 7 | $182.4m |
| Q4 2023 | 7 | $236.2m |
| Q3 2023 | 8 | $175.6m |
| Q2 2023 | 9 | $205.9m |
| Q1 2023 | 7 | $185.1m |
| Q4 2022 | 4 | $125.9m |
| Q3 2022 | 4 | $103.0m |
Counts every tracked manager that disclosed AXSM in that quarter's filing, including managers that have since stopped filing.